BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17603925)

  • 1. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Calabrese V
    Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Dalle-Donne I
    Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
    [No Abstract]   [Full Text] [Related]  

  • 3. Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Estévez AG
    Free Radic Biol Med; 2007 Jul; 43(2):163-4. PubMed ID: 17603926
    [No Abstract]   [Full Text] [Related]  

  • 4. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
    Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
    Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
    Liu D; Bao F; Wen J; Liu J
    Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
    Aoki M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
    Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
    Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.
    Nguyen MD; Larivière RC; Julien JP
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12306-11. PubMed ID: 11050249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
    Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
    Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
    McCord JM
    Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
    Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
    J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
    Dal Canto MC
    Clin Neurosci; 1995-1996; 3(6):332-7. PubMed ID: 9021254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathological study of patient with familial amyotrophic lateral sclerosis associated with a two-base pair deletion in the copper/zinc superoxide dismutase (SOD1) gene.
    Kadekawa J; Fujimura H; Yanagihara T; Sakoda S
    Acta Neuropathol; 2001 Apr; 101(4):415. PubMed ID: 11355314
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amyotrophic lateral sclerosis and cognitive disorders: review and analysis of the literature].
    Portet F; Touchon J; Camu W
    Rev Neurol (Paris); 2001 Feb; 157(2):139-50. PubMed ID: 11283461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
    Gurney ME
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement.
    Fujita Y; Okamoto K; Sakurai A; Gonatas NK; Hirano A
    J Neurol Sci; 2000 Mar; 174(2):137-40. PubMed ID: 10727699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.